Indeed, TACSTD2 (associated with good prognosis) was only significantly higher in expression in the CR and PR cancer-stromal doublets over their cancer cells and fibroblast singlet counterparts, but not the PD group (Fig. 2c). Here, TACSTD2 is linked to cancer.